TLPH Q4 2020 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q4 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$738,000+55.4% YoY

Gross Profit

-$1M-189.4% margin

Operating Income

-$9M-1252.6% margin

Net Income

-$9M-1208.4% margin

EPS (Diluted)

$-1.93

QoQ Revenue Growth

-46.1%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$66M

Total Liabilities

$122M

Stockholders' Equity

-$56M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$738,000	$475,000	+55.4%
Gross Profit	-$1M	-$2M	+36.6%
Operating Income	-$9M	-$15M	+38.3%
Net Income	-$9M	-$14M	+38.2%